封面
市场调查报告书
商品编码
1429274

全球体积描记器市场:现况分析与预测(2023-2030)

Plethysmograph Market: Current Analysis and Forecast (2023-2030)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 144 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

体积描记器是一种用于测量器官内或全身体积变化的医疗设备。 在呼吸生理学中,它经常被用来测量肺部空气量的变化。 该设备有助于诊断呼吸系统疾病并评估肺功能。 其他几个因素也在推动全球体积描记术的发展,包括人口老化的加剧和不健康的生活方式。 例如,根据BMC Public Health 的数据,2023 年7 月不健康生活方式的盛行率为:饮食为86.4%,饮酒为14.5%,烟草为6.0%,体力活动为72.2%,萤幕时间为42.3%,睡眠时间为63.9% 。

由于全球烟酒流行率不断上升,体积描记器市场预计将以 4.5% 左右的速度稳定成长。 根据 2021 年全国药物使用与健康调查 (NSDUH),2020 年有 2,950 万名 12 岁及以上的人患有酒精使用障碍 (AUD)。 在预测期内,有几个因素正在推动市场,包括呼吸道疾病患病率上升、对喉癌的认识不断提高、吸烟人口增加、酗酒文化日益盛行以及医疗保健领域投资增加。我们正在促进增长。 除此之外,透过体积描记器提高治疗效率可以加快治疗过程并提高精确度,这也稳步推动了体积描记器市场的发展。

依产品类型分为躯干体积描记器、四肢体积描记器等。 由于能够有效侦测手臂和腿部的阻塞情况,四肢体积描记器将在 2022 年占据全球体积描记器市场的最大份额。 如果它检测到脉搏率存在差异并且手臂和腿之间的脉搏率降低,则可能存在阻塞。 由于老年人口的增加以及吸烟、酗酒等不健康生活习惯的日益普遍,该行业正在主导市场。 因此,四肢体积描记器细分市场将在 2022 年占据主要市场份额。

根据最终用途,市场分为医院、诊所和其他。 到 2022 年,诊所将占据市场的主要份额。 诊所是初级卫生保健机构,患者在这里接受即时诊断、治疗和持续护理。 我们透过提供最先进的医疗设施、专业知识和多学科的患者护理方法,在患者管理中发挥着至关重要的作用。 研究合作和收购的增加正在推动该领域的成长。 因此,诊所类别在预测期内预计将出现更高的复合年增长率。

为了更了解体积描记器的市场介绍,市场包括北美(美国、加拿大、北美其他地区)、欧洲(德国、英国、法国、西班牙、义大利、欧洲其他地区)、亚太地区(中国、日本、印度、亚太地区其他地区)及世界其他地区。 在目前的 2022 年情境中,由于烟雾污染加剧、酒精消费增加以及开发有效体积描记器的投资增加,北美将主导市场。 例如,根据国家药物滥用统计中心的数据,在约翰霍普金斯大学-马里兰大学巴尔的摩分校的一项调查中,60.1% 的参与者表示,自2020 年3 月1 日以来,他们增加了饮酒量。 政府机构已启动心臟病意识计划,为患者提供有效的治疗。 因此,按地区划分,北美将在 2022 年占据较大市场份额。

市场上营运的主要公司包括 ACI Medical, LLC、COSMED srl、D. E. Hokanson Inc.、Geratherm Medical AG、medical Equipment europe GmbH、Medizinische Messtechnik GmbH、MGC Diagnostics Corporation、Morgan Scientific、PulmOne Advanced 。

目录

第一章市场介绍

  • 市场定义
  • 主要目标
  • 利害关係人
  • 限制

第二章研究方法或前提

  • 调查过程
  • 调查方法
  • 受访者简介

第三章市场总结

第 4 章执行摘要

第 5 章 COVID-19 对体积描记器市场的影响

第 6 章体积描记器市场收入,2020-2030

第 7 章市场洞察:依产品类型

  • 躯干体积描记器
  • 四肢体积描记器
  • 其他

第 8 章市场洞察:最终用户

  • 医院
  • 诊所
  • 其他

第 9 章市场洞察:按地区

  • 北美
    • 美国
    • 加拿大
    • 北美其他地区
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 亚太地区其他地区
  • 其他领域

第 10 章体积描记器市场动态

  • 市场驱动因素
  • 市场挑战
  • 影响分析

第 11 章体积描记器的市场机会

第十二章体积描记器市场趋势

第十三章需求方与供给方分析

  • 需求方分析
  • 供给面分析

第14章价值链分析

第15章竞争场景

  • 竞争状况
    • 波特五力分析

第十六章公司简介

  • ACI Medical, LLC
  • COSMED srl
  • D. E. Hokanson Inc.
  • Geratherm Medical AG
  • medical equipment europe GmbH
  • Medizinische Messtechnik GmbH
  • MGC Diagnostics Corporation
  • Morgan Scientific
  • PulmOne Advanced Medical Devices
  • SCHILLER AG

第十七章免责声明

简介目录
Product Code: UMHE212568

A plethysmograph is a medical device used to measure changes in volume within an organ or a whole body part. It's often used in respiratory physiology to measure changes in air volume in the lungs. This device can help diagnose respiratory conditions and assess lung function. Several other factors, such as the rising geriatric population, and unhealthy lifestyles are leading drivers of plethysmographs globally. For instance, according to the BMC Public Health, in July 2023, the prevalence of unhealthy lifestyles was 86.4% for diet, 14.5% for alcohol, 6.0% for tobacco, 72.2% for physical activity, 42.3% for screen time, and 63.9% for sleep duration.

The Plethysmograph Market is expected to grow at a steady rate of around 4.5% owing to the increased prevalence of alcohol and tobacco globally. According to the 2021 National Survey on Drug Use and Health (NSDUH), 29.5 million people ages 12 and older had Alcohol Use Disorder (AUD) in the year 2020. Several factors, including a rising prevalence of respiratory disorders, increasing awareness regarding throat cancer, increasing smoking population, rising alcoholism culture, and increased investments in healthcare departments are driving the growth of the market during the forecast period. Apart from this, accelerated treatment efficiency with plethysmograph has resulted in faster treatment procedures and better accuracy which is also driving this market of plethysmograph at a steady rate.

Based on product type, the market is segmented into body plethysmograph, limbs plethysmograph, and others. The limb plethysmograph segment held the maximum share in the global market of plethysmographs in 2022 owing to its efficiency in detecting blockage in arms and legs. It detects differences between the pulses and if there is a decrease in the pulse between the arm and leg, it may indicate a blockage. This segment dominated the market because of the increasing geriatric population, and increased prevalence of ill lifestyles including smoking, alcoholism, and unhealthy lifestyles among people. Thus, the limb plethysmograph segment held a significant share of the market in 2022.

Based on end use, the market is segmented into hospitals, clinics, and others. The clinics held a significant share of the market in 2022. Clinics serve as primary healthcare institutions where patients receive an immediate diagnosis, treatment, and ongoing care. They play a pivotal role in the management of patients by providing state-of-the-art medical facilities, specialized expertise, and a multidisciplinary approach to patient care. Rising collaborations and acquisitions are boosting this segment's growth. Hence, the clinics category is expected to witness higher CAGR during the forecast period.

For a better understanding of the market adoption of plethysmograph, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is dominating the market in the current scenario of 2022 due to the increasing smoke pollution, increasing alcohol consumption, and rising number of investments in developing effective plethysmograph. For example, according to the National Center for Drug Abuse Statistics, in a Johns Hopkins-University of Maryland-Baltimore survey, 60.1% of participants reported drinking more alcohol after March 1, 2020. Government organizations are initiating cardiac disorder awareness programs to provide efficient care to patients. Thus, amongst regions, North America held a significant share of the market in 2022.

Some of the major players operating in the market include ACI Medical, LLC; COSMED srl; D. E. Hokanson Inc.; Geratherm Medical AG; medical equipment europe GmbH; Medizinische Messtechnik GmbH; MGC Diagnostics Corporation; Morgan Scientific; PulmOne Advanced Medical Devices; SCHILLER AG.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Plethysmograph Market
  • 2.2. Research Methodology of the Plethysmograph Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE PLETHYSMOGRAPH MARKET

6 PLETHYSMOGRAPH MARKET REVENUE (USD BN), 2020-2030F

7 MARKET INSIGHTS BY PRODUCT TYPE

  • 7.1. Body Plethysmograph
  • 7.2. Limbs Plethysmograph
  • 7.3. Others

8 MARKET INSIGHTS BY END-USER

  • 8.1. Hospitals
  • 8.2. Clinics
  • 8.3. Others

9 MARKET INSIGHTS BY REGION

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. U.K.
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Rest of Asia-Pacific
  • 9.4. Rest of World

10 PLETHYSMOGRAPH MARKET DYNAMICS

  • 10.1. Market Drivers
  • 10.2. Market Challenges
  • 10.3. Impact Analysis

11 PLETHYSMOGRAPH MARKET OPPORTUNITIES

12 PLETHYSMOGRAPH MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 13.1. Demand Side Analysis
  • 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 COMPETITIVE SCENARIO

  • 15.1. Competitive Landscape
    • 15.1.1. Porters Fiver Forces Analysis

16 COMPANY PROFILED

  • 16.1. ACI Medical, LLC
  • 16.2. COSMED srl
  • 16.3. D. E. Hokanson Inc.
  • 16.4. Geratherm Medical AG
  • 16.5. medical equipment europe GmbH
  • 16.6. Medizinische Messtechnik GmbH
  • 16.7. MGC Diagnostics Corporation
  • 16.8. Morgan Scientific
  • 16.9. PulmOne Advanced Medical Devices
  • 16.10. SCHILLER AG

17 DISCLAIMER